Pasteur Institute
Paris, Paris, France
Purpose
to complete the laboratory development of the remaining two components of a new Shigella 4-valent Synthetic Conjugate Vaccine to prevent Shigella diarrhea and dysentery among children in LMICs.
Division
Global Health
Date
May 2018
Region Served
GLOBAL
Committed amount
$593,706
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
35
Grantee location
Paris, Paris, France
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.